Delivery Order SPE2DB24D6041-SPE2DB25FKBUZ
- Not listed
- The Defense Logistics Agency awarded a $4,240.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 26, 2026. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits under a firm fixed-price contract. The order, issued on December 31, 2025, with completion targeted for January 23, 2026, represents a non-set-aside competitive award to support federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $1,584.52 and an ultimate completion date of December 24, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits under a firm fixed-price contract with a ceiling value of $2,911.28. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 26, 2025, for Zymfentra 120 mg/ml pen kits valued at $3,007.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of October 20, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a ceiling value of $1,584.52. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $3,169.04 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, a pharmaceutical product to support federal medical supply needs. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by December 17, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,240.82 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with performance in Conshohocken, Pennsylvania and completion by January 29, 2026. This non-competitive delivery order was awarded on January 7, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as...
- On November 26, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,169.04 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with a completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $4,240.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on January 12, 2026, with a completion date of February 3, 2026. This non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. and functions as a critical pharmaceutical distributor serving the federal medical...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKBUZDelivery Order
The Defense Logistics Agency awarded a $4,212.90 delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of April 1, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA's Medical Supply Chain. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and specialized medical commodities. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 3/10/25 |